September 21, 2016
8:00-9:00 a.m.
Smilow Center for Translational Research, Rubenstein Auditorium
Sriram Venigalla, MD, Radiation Oncology Fellow
Insufficiency fracture following pelvic radiotherapy: an overlooked complication
Elise Chong, MD, Hematology/Oncology
Administration of Rituximab on a Non-Oncology Floor
Target Audience
This program has been designed for physicians, fellows, residents, medical students, physician assistants, professional nurses, advanced practice nurses, nursing studentsin the medical specialties of internal medicine, medical genetics and genomics, nuclear medicine, obstetrics and gynecology, ophthalmology, otolaryngology, pathology, pediatrics, physical medicine and rehabilitation, radiology, and urology.
Series Educational Objectives
After completing this activity, participants should be able to:
- Describe and define the pathophysiology and etiology of oncologic diseases
- Explain and employ new diagnostic methods for different oncologic diseases
- Formulate and prescribe a management plan for different oncologic diseases
- Access and grade prognostic information about different oncologic diseases
Accreditation
Physicians: The Perelman School of Medicine at the University of Pennsylvania is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Nurses: Penn Medicine Nursing is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Approval # 124-3-H-15
Designation of Credit
Physicians: The Perelman School of Medicine at the University of Pennsylvania designates this live activity for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: Nurse participants will be awarded 1.0 contact hour.
Approved for (PSRM) patient safety/risk management designation
Acknowledgement of Commercial Support* NONE
For more information, please contact
Joy Junious
215-662-3917
Disclosure of Relevant Financial Relationships and Unapproved Uses of Products
It is policy at the Perelman School of Medicine at the University of Pennsylvania and the Hospital of the University of Pennsylvania, Department of Nursing Education, Innovation and Professional Developmentfor individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provide products or services that may be relevant to the content of this continuing education activity. For this purpose we consider relationships of the person involved to include financial relationships of a spouse or partner.
The intent of this policy is to ensure that Penn CME/CNE certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information was found to contain relationships that created a conflict of interest relevant to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.
The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania, Mila Kostic, CHCP, FACEHP, Director of CME,Zalman Agus, MD,Senior peer reviewerand Patricia A. Smith, DNP, RN-BC,Nursing professional development specialist of the HUP Department of Nursing Innovation and Development have disclosed that they have norelevant financial relationships with any commercial interests related to the content of this educational activity.
The following individuals have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:
Planning Committee & Presneter Name
Joseph R. Carver, MD / Eli Glatstein, MD / Chi Dang, MD, PhDAlison Loren, MD / Patricia Gambino, MSN, RN
Presenter Name
William Tristram Arscott, MD / Adham Bear, MD / Hann-Hsiang Chao, MDElise Chong, MD / Tara Kaufmann, MD / Melina Marmarelis, MD
Kevin Nead, MD / Joanna Rhodes, MD / Nathan Singh, MD
Scott Pesiak, MD / Samuel Takvorian, MD / Sriram Venigalla, MD
The following individuals have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity.
Planning Committee & Presenter NameName of Commercial InterestRelationship
Selina Luger, MDPfizerDSMB
Toledo, Novartis, KangopharmAdvisory Board
AmgenClinical Trial
David Vaughn, MDAstellasDSMB
Presenter NameName of Commercial InterestRelationship
Relevant financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected
Disclosure of Unapproved Uses of Products
Presenter nameProductInvestigational and/or Off-label Use